[go: up one dir, main page]

RU2014142874A - A method of treating a hangover syndrome in persons not related to patients with alcoholism - Google Patents

A method of treating a hangover syndrome in persons not related to patients with alcoholism Download PDF

Info

Publication number
RU2014142874A
RU2014142874A RU2014142874A RU2014142874A RU2014142874A RU 2014142874 A RU2014142874 A RU 2014142874A RU 2014142874 A RU2014142874 A RU 2014142874A RU 2014142874 A RU2014142874 A RU 2014142874A RU 2014142874 A RU2014142874 A RU 2014142874A
Authority
RU
Russia
Prior art keywords
treating
mexidol
patients
alcoholism
persons
Prior art date
Application number
RU2014142874A
Other languages
Russian (ru)
Inventor
Андрей Александрович Власов
Наталья Александровна Власова
Original Assignee
Андрей Александрович Власов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Андрей Александрович Власов filed Critical Андрей Александрович Власов
Priority to RU2014142874A priority Critical patent/RU2014142874A/en
Publication of RU2014142874A publication Critical patent/RU2014142874A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Способ лечения похмельного синдрома у лиц, не относящихся к больным алкоголизмом, путем применения мексидола, отличающийся тем, что мексидол используют в качестве монопрепарата, при этом мексидол вводиться в виде единоразовой дозы, однократно, капельно внутривенно в дозировке 200 мг в составе 200 мл 0,9% раствора натрия хлорида на протяжении 2-х часов.A method of treating a hangover syndrome in non-alcoholic patients by using Mexidol, characterized in that Mexidol is used as a single drug, Mexidol being administered as a single dose, once, drip intravenously at a dosage of 200 mg in a composition of 200 ml 0, 9% sodium chloride solution for 2 hours.

Claims (1)

Способ лечения похмельного синдрома у лиц, не относящихся к больным алкоголизмом, путем применения мексидола, отличающийся тем, что мексидол используют в качестве монопрепарата, при этом мексидол вводиться в виде единоразовой дозы, однократно, капельно внутривенно в дозировке 200 мг в составе 200 мл 0,9% раствора натрия хлорида на протяжении 2-х часов. A method of treating a hangover syndrome in non-alcoholic patients by using Mexidol, characterized in that Mexidol is used as a single drug, Mexidol being administered as a single dose, once, drip intravenously at a dosage of 200 mg in a composition of 200 ml 0, 9% sodium chloride solution for 2 hours.
RU2014142874A 2014-10-23 2014-10-23 A method of treating a hangover syndrome in persons not related to patients with alcoholism RU2014142874A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014142874A RU2014142874A (en) 2014-10-23 2014-10-23 A method of treating a hangover syndrome in persons not related to patients with alcoholism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014142874A RU2014142874A (en) 2014-10-23 2014-10-23 A method of treating a hangover syndrome in persons not related to patients with alcoholism

Publications (1)

Publication Number Publication Date
RU2014142874A true RU2014142874A (en) 2016-05-20

Family

ID=56011810

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014142874A RU2014142874A (en) 2014-10-23 2014-10-23 A method of treating a hangover syndrome in persons not related to patients with alcoholism

Country Status (1)

Country Link
RU (1) RU2014142874A (en)

Similar Documents

Publication Publication Date Title
MX2022003072A (en) Use of pridopidine for treating functional decline.
CY1122648T1 (en) PROCESS FOR THE PREPARATION OF COMPOSITIONS CONTAINING HYALURONIC ACID AND MEPIVACAINE HYDROCHLORIDE
EA201691151A1 (en) CONNECTIONS FOR THE TREATMENT OF PATIENTS WITH ROS1-MUTANT CANCER CELLS
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
EA201690287A1 (en) 1,4-DESIGNED ANALOGUES OF PYRIDAZIN QUINOLINE AND METHODS OF TREATING CONDITIONS ASSOCIATED WITH SMN-DEFICIENCY
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
MX381440B (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCERATIVE COLITIS.
AR101674A1 (en) USE OF A TRICYCLIC COMPOUND CONTAINING NITROGEN
MX390084B (en) P2X3 AND P2X2/3 DIAMINOPYRIMIDINE RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGH.
AR096892A1 (en) A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA
FI3685847T3 (en) Modulators of complement activity
MY176246A (en) Compositions for oral administration of zoledronic acid or related compounds for treating disease
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
EA201790223A1 (en) WATER PREPARATION CONTAINING PARACETAMOL AND IBUPROFEN
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
EA201992382A3 (en) ORAL TABLET PHARMACEUTICAL COMPOSITION FOR DOUBLE USE ON THE BASIS OF SULPHATE SALTS AND METHODS OF ITS APPLICATION
CL2016002318A1 (en) Pharmaceutical composition in the form of a solution comprising a liquid carrier comprising water and between 20% and 95% of one or more alcohols and sildenafil citrate dissolved in said liquid carrier at a concentration of between 7 and 125 mg / ml; methods to obtain it; oral dosage form; oral dosage form; kits
EA201591653A1 (en) COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL
MX2017015202A (en) Liquid formulations of celecoxib for oral administration.
PH12016501026A1 (en) Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor
RU2014142874A (en) A method of treating a hangover syndrome in persons not related to patients with alcoholism
MX2019007360A (en) Azabicyclo-substituted triazole derivative, preparation method thereof, and application of same in medicine.
RU2014106575A (en) METHOD FOR PREVENTION OF BLEEDING WITH MYOMECTOMY
RU2012115039A (en) METHOD FOR TREATING CHRONIC ENDOMETRITIS
RU2013127881A (en) APPLICATION OF THE PHARMACEUTICAL COMPOSITION BASED ON THE SALT OF QUATERNARY PHOSPHONY AND SUBSTITUTED DINITROBENZOFUROXAN FOR THE TREATMENT OF Pyroplasmosis in Dogs and the Method of Treatment